Three fund managers on stocks that are whetting their appetite
There are ways investors can benefit from the burgeoning healthcare sector across developing nations, without having to undergo the “challenging” research and development process that drug companies have to endure, according to Aubrey Capital Management’s Mark Martyrossian.
Comments